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OBJECTIVE: To evaluate the profile of osteoporosis treatment among patients hospitalized due to hip fractures at a tertiary-level 
university hospital. To compare the impact of hospitalization on approaches toward treating bone mass losses. 
METHOD: The medical records of 123 hip fracture patients aged 60 years and over at the Institute of Orthopedics, Hospital das 
Clínicas, University of São Paulo School of Medicine, between 2004 and 2006 were reviewed and analyzed with respect to ap-
proaches towards investigating osteoporosis and treatments before and after fracture. 
RESULTS: The patients’ mean age was 78 ± 8.3 years, and the majority were women (71.54%). The patients had a mean of 2.72 
comorbidities and used 3.26 medications on average. Among these patients, 12.3% reported a previous diagnosis of osteoporosis, 
and 5.83% were on medication for this. The mean waiting time for surgery was 6.3 ± 7.54 days, and seven patients (5.7%) died 
during the hospitalization. There were no investigations using bone densitometry, no changes in osteoporosis therapy between 
admission and discharge (p = 0.375), and no reports of referrals for the patient to have access to treatment.
CONCLUSIONS: Investigations and treatments of osteoporosis and strategies for preventing new fractures were not implemented 
during the hospitalization of these elderly patients with hip fractures, even though this is the most feared complication of osteopo-
rosis. These data need to be disseminated so that professionals dealing with elderly patients are attentive to the need for primary 
and secondary prevention of osteoporosis because of the impact of fractures on these patients’ quality of life, independence, mor-
bidities, and mortality. 
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INTRODUCTION
The aging of the population has presented a series of 
challenges for the healthcare system worldwide. One of the 
main challenges is to maintain functionality within society. 
In this context, osteoporosis is of fundamental importance, 
both because of its high prevalence and because it is a risk 
factor for hip fractures.1,2 Hip fractures are related with high 
rates of complications within hospitals, mortality within the 
first year after the trauma, and institutionalization.3-5
Patients who have already suffered some kind of fracture 
due to osteoporosis have a five times greater risk of suffering 
a new episode compared to the population without any 
antecedents of osteoporosis or previous fractures.3 This 
segment of the population seems to be the one that would 
most benefit from the various treatments for osteoporosis 
that are currently available. These treatments may increase 
bone mass and reduce the risk of fractures by up to 40-
60%.4,5 However, recent studies have demonstrated that 
physicians are missing opportunities to intervene with regard 
to prevention of secondary fractures. 6,7,8,9 
METHOD
The medical records of patients over 60 years old, of 
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both sexes, admitted in our hospital between 2004 and 
2006 with a diagnosis of hip fracture, were reviewed and 
analyzed for approaches toward investigating osteoporosis 
and treatments before and after the fracture. 
Investigation was also made regarding comorbidities and 
the number of medications taken per patient.
This research was approved by the ethical committee of 
Hospital das Clínicas, University of São Paulo School of 
Medicine.
RESULTS
The patients were 78 ± 8.3 years old, predominantly 
female (71.54%) with a mean of 2.72 ± 1.81 comorbidities 
and taking a mean of 3.26 ± 2.86 medications. 
Among these patients, only 12.3% reported a diagnosis 
of osteoporosis, while 8.13% had histories of previous 
femoral or radial fractures, and 5.83% were under 
medication for osteoporosis (Table 1). 
Age (p=0.97), sex (p=0.08), and number of comorbidities 
(p=0.123) were not statistically correlated with previous 
treatment for osteoporosis. Nonetheless, the patients using 
fewer medications were receiving treatment more frequently 
(p=0.007). 
During the hospitalizations, there were no investigations 
of any cases that utilized bone densitometry, and there were 
no changes in therapy between admission and discharge 
(p=0.375). On the contrary, there was a tendency toward 
prescribing fewer medications at discharge (Table 1). The 
patients didn’t report previous investigations or treatment 
for osteoporosis.
DISCUSSION
Our results show that in our population, even before 
hospitalization, the rates of diagnosis and treatment of 
osteoporosis are low. In fact, only 12.3% had a previous 
diagnosis of osteoporosis and 8.13% had previous fractures. 
In addition, only 5.83% were in treatment for osteoporosis. 
In other words, only a minority (43%) of patients with 
previous confirmed osteoporosis diagnosis were under any 
kind of treatment before the hip fracture.
In our study, this lack of interventions continued even 
during hospitalization for hip fractures, even though the 
elderly is a segment of the population with a greater risk of 
new fractures. 
Similar data are reported in other countries. In Australia, 
Smith et al. demonstrated that among patients with hip or 
wrist fractures, only 34% had received some type of medical 
information, only 32% had undergone bone densitometry, 
and only 39% had received treatment for osteoporosis. Most 
patients were treated only with calcium supplementation.10 
In the United States, out of 142 patients with hip fractures, 
none had undergone bone densitometry, and hospitalization 
did not modify the treatment profile among these patients, 
even if they received follow-up from geriatricians or 
clinicians.11
Among male patients, the lack of treatment is even 
more evident, although this segment of the population 
accounts 20-30% of hip fractures. In a study at the National 
Traumatology-Orthopedics Institute, the incidence of 
osteoporosis among community-dwelling men over the 
age of 80 years was 36.4%, and the incidence was over 
68% among individuals with low body mass index.12 More 
alarmingly, the mortality rate at 12 months after fracture is 
greater among men than among women (32% versus 17%, 
respectively).13
There are various reasons for this practically universal 
absence of investigation and treatment of osteoporosis while 
patients are hospitalized due to hip fractures. On the one 
hand, some professionals seem to assume that, particularly 
in the case of very elderly people (over 85 years of age), the 
treatment will be inefficient.10 On the other hand, the use of 
bisphosphonates during the acute phase of fracture recovery 
is in fact controversial, given that it is postulated that the 
mechanism of anti-reabsorption of these agents could 
impair bone consolidation following surgical repair. Despite 
scanty evidence and lack of proof, it has been reported that 
long-term treatment with bisphosphonates, particularly if 
associated with other agents like estrogen, could lead to 
occurrence of stress fractures with slower healing.14,15,16
As for investigations of osteoporosis among patients 
who already present fractures due to frailness, reasons for 
the observed results may include the existence of an attitude 
that such investigations are redundant, considering that such 
fractures are already diagnostic criteria for osteoporosis.17 
Nevertheless, it can be argued that these investigations would 
serve to raise awareness among professionals, so that they 
would treat osteoporosis or contribute to risk forecasting.
One possible explanation for minimal treatment for 
Table 1 - Type of treatment on admission and at discharge
  
Admission n (%) Discharge n (%)
ALENDRONATE 3 (2.50%) 1 (0.88%)
CALCIUM 7 (5.83%) 3 (2.65%)
VITAMIN D 3 (2.50%) 3 (2.65%)
CALCITRIOL 1 (0.83%) 0 (0%)
TERIPARATIDE 0 (0%) 0 (0%)
RALOXIFENE 1 (0.83%) 0 (0%)
Note: Some patients received more than one treatment
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osteoporosis during the acute phase of the fracture is that the 
surgical team’s priority is almost exclusively directed toward 
correcting the fracture and seeking to provide conditions 
of mobility for the patient, in order to avoid perioperative 
complications. From this perspective, the benefit of 
treatment for such patients might be grasped if the team were 
interdisciplinary.18 
The strategies recommended for improving treatment for 
these patients include systematic education for healthcare 
professionals, objective reminders, preparation of algorithms 
and guidelines, and combined follow-up conducted by both 
the geriatrician and the orthopedist throughout the hospital 
stay.19,20 Furthermore, collaboration between medical teams 
has been shown to be effective, with a lower mortality rate 
during hospitalization and the return of most patients to their 
homes after discharge.19
Within our  set t ing,  the establ ishment  of  an 
interdisciplinary team outpatient service for postoperative 
follow-up among elderly patients treated for fractures started 
a few months ago. The aim was to control these patients’ 
conditions by providing support to cope with the limitations 
inherent to their frailness and osteoporosis. We believe 
that this type of intervention, as used in the Department of 
Orthopedics in USA may enable better-adapted and more 
efficient treatment of patients who present fractures due 
to their frailness.21 The previous experience in our service 
with elderly patients in other types of pathology confirms 
this idea.22,23
CONCLUSIONS
Investigation and treatment of osteoporosis and strategies 
for preventing new fractures were not established before 
and while these elderly patients were hospitalized due to hip 
fractures. In many countries, preventive treatment is regarded 
as having little value. The possibility of preventive measures 
for these patients requires strategies to alert the health team 
and coordination of interprofessional care.
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